Back to results
US 9,314,453 B2Granted
Tetrahydropyridoethers for treatment of AMD
AssigneeKatairo GmbH
InventorUlrich Schraermeyer
Life of this patent
Estimating the term…
Abstract
A medication comprising tetrahydropyridoethers for use in the treatment of AMD.
Claims17
A method of treatment of dry AMD in a subject, comprising:
- administering to the subject in need of such treatment a medication comprising a compound according to the following formula I as active ingredient in suitable amount,
- in which
- R1 is methyl or hydroxymethyl, one of the substituents R2a and R2b is hydrogen and the other is hydroxy, methoxy, ethoxy, isopropoxy, methoxyethoxy or ethoxypropoxy, one of the substituents R3a and R3b is hydrogen and the other is hydroxy, methoxy, ethoxy, isopropoxy, methoxyethoxy or methoxypropoxy, where R2a or R2b on the one hand and R3a or R3b on the other hand are not simultaneously hydroxy, and its salts.
A method of treatment of dry AMD in a subject, comprising:
- administering to the subject in need of such treatment a medication comprising a compound according to the following formula as active ingredient in a suitable amount,
- in which R1 is methyl or hydroxymethyl, one of the substituents R2a and R2b is hydrogen and the other is hydroxy, methoxy, ethoxy, isopropoxy, methoxyethoxy or ethoxypropoxy, one of the substituents R3a and R3b is hydrogen and the other is hydroxy, methoxy, ethoxy, isopropoxy, methoxyethoxy or methoxypropoxy, where R2a or R2b on the one hand and R3a or R3b on the other hand are not simultaneously hydroxy, and its salts.
A method of treatment of dry AMD in a subject, comprising:
- administering to the subject in need of such treatment a medication comprising a compound according to the following formula I** as active ingredient in a suitable amount,
- wherein one of the substituents Ra and Rb is hydrogen and the other is methoxy, ethoxy, isopropoxy, methoxyethoxy or methoxypropoxy, and its salts.
Dependencies are inferred from the claim text.